** Australian healthcare stocks .AXHJ slip 1.2% to a one-week low, extending declines from previous session
** Vaccine maker CSL CSL.AX down 1.8%; biopharma Telix TLX.AX drops 3.3%
** US President Trump signs executive order aiming to reduce approval time for local pharma plants to encourage domestic manufacturing; plans pharma tariffs in next two weeks
** Australian healthcare firms largely depend on exports to the U.S. and are hurt by a strong Australian dollar, which has hit a new five-month peak. AUD/
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.kumar@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。